Inventor
XIONG YIFENG
US46 patents
⚠️ This page may combine multiple inventors who share the name “XIONG YIFENG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARENA PHARM INC
18 patentsUS7884101B2Feb 8, 2011
3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC42 citations95
US7132426B2Nov 7, 2006
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
ARENA PHARM INC56 citations95
US7838525B2Nov 23, 2010
Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
ARENA PHARM INC39 citations92
US7470699B2Dec 30, 2008
Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
ARENA PHARM INC41 citations92
US9732039B2Aug 15, 2017
Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC17 citations91
US10632134B2Apr 28, 2020
Cannabinoid receptor modulators
ARENA PHARM INC5 citations83
US9867822B2Jan 16, 2018
Cannabinoid receptor modulators
ARENA PHARM INC7 citations83
US9492447B2Nov 15, 2016
Cannabinoid receptor modulators
ARENA PHARM INC9 citations83
US7625906B2Dec 1, 2009
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
ARENA PHARM INC11 citations83
US11771695B2Oct 3, 2023
Cannabinoid receptor modulators
ARENA PHARM INC4 citations74
US10058549B2Aug 28, 2018
Imidazo[1,2-α]pyridine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC4 citations73
US11214548B2Jan 4, 2022
Cannabinoid receptor modulators
ARENA PHARM INC3 citations72
US9676758B2Jun 13, 2017
1-heteroaryl-indoline-4-carboxamides as modulators of GPR52 useful for the treatment or prevention of disorders related thereto
ARENA PHARM INC3 citations66
US12109219B2Oct 8, 2024
Cannabinoid receptor modulators
ARENA PHARM INC0 citations62
US11746091B2Sep 5, 2023
Cannabinoid receptor modulators
ARENA PHARM INC0 citations62
US10781180B2Sep 22, 2020
3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC0 citations51
US10351531B2Jul 16, 2019
Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC0 citations51
US9365511B2Jun 14, 2016
Biphenyl-ethyl-pyrrolidine derivatives as histamine H3 receptor modulators for the treatment of cognitive disorders
ARENA PHARM INC0 citations51
POSITION IMAGING INC
8 patentsUS10444323B2Oct 15, 2019
Expandable, decentralized position tracking systems and methods
POSITION IMAGING INC24 citations91
US10200819B2Feb 5, 2019
Virtual reality and augmented reality functionality for mobile devices
POSITION IMAGING INC3 citations73
US11922246B2Mar 5, 2024
Article-identification-and-location device systems and methods of using same
POSITION IMAGING INC4 citations72
US12011073B2Jun 18, 2024
Article-identification-and-location device systems and methods of using same
POSITION IMAGING INC2 citations71
US11107337B2Aug 31, 2021
Article-identification and location device systems and methods of using same
POSITION IMAGING INC6 citations71
US11637962B2Apr 25, 2023
Computer-vision-based object tracking and guidance module
POSITION IMAGING INC0 citations59
US11089232B2Aug 10, 2021
Computer-vision-based object tracking and guidance module
POSITION IMAGING INC0 citations59
US10631131B2Apr 21, 2020
Virtual reality and augmented reality functionality for mobile devices
POSITION IMAGING INC0 citations52
JONES ROBERT M
6 patentsUS8778950B2Jul 15, 2014
Cannabinoid receptor modulators
JONES ROBERT M21 citations92
US8410119B2Apr 2, 2013
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
JONES ROBERT M8 citations82
US8293751B2Oct 23, 2012
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
JONES ROBERT M8 citations78
US9944606B2Apr 17, 2018
Cannabinoid receptor modulators
JONES ROBERT M3 citations72
US8546429B2Oct 1, 2013
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
JONES ROBERT M0 citations51
US8933083B2Jan 13, 2015
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
JONES ROBERT M0 citations46
CONTINEUM THERAPEUTICS INC
3 patentsUS12054487B2Aug 6, 2024
Muscarinic acetylcholine M1 receptor antagonists
CONTINEUM THERAPEUTICS INC2 citations64
US12390462B2Aug 19, 2025
Muscarinic acetylcholine M1 receptor antagonists
CONTINEUM THERAPEUTICS INC0 citations57
US12565501B2Mar 3, 2026
Muscarinic acetylcholine M1 receptor antagonists
CONTINEUM THERAPEUTICS INC0 citations47
XIONG YIFENG
2 patentsUS9567327B2Feb 14, 2017
Imidazo[1,2-a]pyridine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
XIONG YIFENG57 citations96
US9434692B2Sep 6, 2016
Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
XIONG YIFENG18 citations90